Rutacid tablets chewable

Nchi: Armenia

Lugha: Kiingereza

Chanzo: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

Viambatanisho vya kazi:

hydrotalcite

Inapatikana kutoka:

KRKA d.d.

ATC kanuni:

A02AD04

INN (Jina la Kimataifa):

hydrotalcite

Kipimo:

500mg

Dawa fomu:

tablets chewable

Vitengo katika mfuko:

(20/2x10/) in blister, (60/6x10/) in blister

Dawa ya aina:

OTC

Idhini hali ya:

Registered

Idhini ya tarehe:

2018-11-27

Tabia za bidhaa

1.3.1
Hydrotalcite
SPC, Labeling and Package Leaflet
AM
SmPCPIL116083_1
14.08.2018 – Updated: 14.08.2018
Page 1 of 5
1.
NAME OF THE MEDICINAL PRODUCT
Rutacid 500 mg chewable tablets
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Each chewable tablet contains 500 mg hydrotalcite.
For a full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Chewable tablet.
Tablets are round, white or almost white with beveled edges and with a
slight peppermint odour.
4.
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Rutacid tablets eliminate or relieve symptoms associated with
excessive gastric acid secretion:
-
belching, heartburn,
-
burning pain in the stomach,
-
inflammation of the lining of the stomach (gastritis), which is a
result of stress, improper diet,
excessive consumption of alcohol or nonsteroidal anti-inflammatory
drugs.
Rutacid tablets promote the healing of gastric and duodenal ulcers and
are also effective in the
maintenance treatment of chronic ulcer disease.
4.2
POSOLOGY AND METHOD OF ADMINISTRATION
The chewable tablets should not be swallowed whole but should be
chewed thoroughly.
_Adults _
The recommended dose is 1 to 2 tablets 3 to 4 times daily, usually one
hour after a meal and at
bedtime, or when the above-mentioned problems occur.
_Elderly _
No dosage adjustment is required.
_Patients with impaired renal function _
Patients with impaired renal function can take Rutacid only for a
short time and at lower doses (see
section 4.4).
_Patients with impaired liver function _
No dosage adjustment is required.
_Children _
The recommended dose for children aged 6 to 12 years is half the adult
dose (½ to 1 tablet) taken 3 to
4 times daily, usually one hour after a meal and at bedtime, or when
problems occur.
Rutacid is not recommended for use in children under 6 years of age
because its safety and efficacy
have not been established.
1.3.1
Hydrotalcite
SPC, Labeling and Package Leaflet
AM
SmPCPIL116083_1
14.08.2018 – Updated: 14.08.2018
Page 2 of 5
4.3
CONTRAINDICATIONS
Hypersensitivity to the active su